液泡型H+-ATP酶通过溶酶体-线粒体轴维持心磷脂稳态以抑制心脏衰老
本研究探讨v-ATP酶功能障碍是否通过破坏心磷脂代谢和线粒体功能驱动年龄相关心脏改变。研究发现NAD+水平下降削弱醛缩酶与v-ATP酶相互作用,导致溶酶体酸化受损、组织蛋白酶B泄漏至线粒体,破坏CRLS1并损害心磷脂合成与重塑,进而引起线粒体氧化应激和程序性细胞死亡。恢复NAD+水平可挽救溶酶体酸化和心磷脂代谢,保护啮齿类动物和人类免受年龄相关心肌病。
要点
- NAD+下降通过削弱醛缩酶与v-ATP酶相互作用损害溶酶体酸化。
- 组织蛋白酶B泄漏至线粒体破坏CRLS1,导致心磷脂缺乏和线粒体功能障碍。
- 恢复NAD+水平可挽救溶酶体酸化和心磷脂代谢,保护心脏。
核心结论
- 增强v-ATP酶介导的溶酶体酸化可通过重编心磷脂稳态来对抗年龄相关心肌病。
研究设计与样本
- 使用RNA测序、靶向脂质组学、免疫荧光显微镜、共免疫沉淀、邻近连接 assay、亚细胞分级、线粒体呼吸分析和超声心动图。
- 采用心磷脂合酶-1(Crsl1)敲除小鼠模型和2种v-ATP酶敲除模型。
- 评估靶向v-ATP酶功能障碍的营养干预能否减轻衰老小鼠模型和老年人的心力衰竭。
主要发现
- 心脏NAD+水平下降通过削弱NAD+依赖性糖酵解酶醛缩酶与v-ATP酶的相互作用,损害v-ATP酶介导的溶酶体酸化。
- 溶酶体酸化减少增加溶酶体膜通透性,使组织蛋白酶B泄漏至线粒体,破坏线粒体CRLS1,损害心磷脂合成和重塑。
- 心磷脂缺乏导致线粒体氧化应激和程序性细胞死亡,引起线粒体和心脏功能障碍。
- 遗传或化学抑制v-ATP酶和CRLS1在小鼠模型中重现这些年龄相关缺陷。
- 恢复NAD+水平可挽救溶酶体酸化和心磷脂代谢,保护啮齿类动物和人类免受年龄相关心肌病。
临床怎么用
- 增强v-ATP酶介导的溶酶体酸化可能成为对抗年龄相关心肌病的新治疗策略。
- 恢复NAD+水平是保护心脏衰老的潜在干预方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac aging involves progressive mitochondrial dysfunction, contributing to heart failure. Cardiolipin (CL), essential for mitochondrial function, is increasingly depleted in aging cardiomyocytes, promoting mitochondrial decline. Lysosomal degradation relies on v-ATPase (vacuolar-type H+-ATPase)-mediated acidification, and although lysosomes regulate phospholipid metabolism, their roles in CL homeostasis during aging remains unclear. This study examines whether v-ATPase dysfunction drives age-related cardiac changes by disrupting CL metabolism and mitochondrial function. METHODS: To investigate underlying mechanisms and causality, we use RNA sequencing, targeted lipidomics, immunofluorescence microscopy, co-immunoprecipitation, proximity ligation assays, subcellular fractionation, mitochondrial respiration analysis and echocardiography, a cardiolipin synthase-1 (Crsl1) knockout mouse model, and 2 v-ATPase knockout models. In addition, we assess whether a nutraceutical intervention targeting v-ATPase dysfunction can mitigate heart failure in aging mouse models and elderly people. RESULTS: Our present findings reveal a sequence of events driving age-related cardiomyopathy: declining cardiac nicotinamide adenine dinucleotide levels impair v-ATPase-mediated lysosomal acidification by weakening the interaction between nicotinamide adenine dinucleotide-dependent glycolytic enzyme aldolase and v-ATPase. This disruption increases lysosomal membrane permeability by reducing lysosomal acidification, allowing cathepsin B to leak into mitochondria. There, cathepsin B disrupts mitochondrial CRLS1 (cardiolipin synthase I), impairing CL synthesis and remodeling. The resulting CL deficiency causes mitochondrial oxidative stress and programmed cell death, leading to mitochondrial and cardiac dysfunction. Genetic or chemical inhibition of v-ATPase and of CRLS1 in mouse models reproduce these age-related defects, highlighting their central roles in cardiac aging. Restoring nicotinamide adenine dinucleotide levels rescues lysosomal acidification and CL metabolism, protecting against age-related cardiomyopathy in rodents and humans. CONCLUSIONS: Augmenting v-ATPase-mediated lysosomal acidification offers novel therapeutic strategies to combat age-related cardiomyopathy by rewiring CL homeostasis.
引用
- Tie H, Hou M, Li Y, et al. Vacuolar H+-ATPase Preserves Cardiolipin Homeostasis Through the Lysosomal-Mitochondrial Axis to Restrain Cardiac Aging. Circulation. 2026. PMID: 42305091. doi:10.1161/CIRCULATIONAHA.125.078376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。